Ascil Biopharm


Contact information

Ascil Biopharm
Laurence Lachamp, Co-founder - Director Business Innovation
Parc UPC BarcelonaTech camí de les filipines 110 08840
Areas of activities
  • A. Health Biotechnology
    • Areas of activity
      • Medical devices
      • Drug delivery
      • Drug development
      • Vaccines
    • Therapeutic areas
      • Analgesia & Pain
      • Dermatology
      • Infectious diseases
      • Inflammatory diseases
      • Gynaecology and obstetrics
      • Immunology
      • Ophtalmology and optometry
      • Oncology
      • Central nervous system
      • Metabolic disorders / Endocrinology
  • B. Agrifood Biotechnology
    • Agriculture / veterinary / environmental
      • Animal health / Veterinary
  • C. Industrial Biotechnology
    • Monomers and polymers
  • D. Services
    • R&D services
      • Nanotechnology and in silico biology
      • CRO / CMO / SMO
    • Professional services
      • Consultancy
      • Supplies and materials providers

Ascil Biopharm develops patented injectable and locally acting therapeutics with advanced Drug Delivery Systems (DDS) —formulations and medical devices— to enhance the safety, effectiveness and convenience of administration of drugs for chronic high burden diseases.

The company's fields of activity are the Lifesciences and Healthcare, including Human health (Pharma and Biotech), Animal health and Dermo-cosmetic care innovations.

Products and services

Ascil differential know-how lies in the design of new product-device combinations adapted to unmet therapeutic needs.

We can offer a set of patented technologies platforms on formulation, devices and process for DDS and Controlled delivery systems (Immediate release dosage forms, sustained release dosage forms) and Innovation projects.

Ascil's know-how and experience deals with the following R&D+I scientific areas:

  • Preformulation, formulation, physico-chemistry & pharmaceutical analysis innovation and development focused on Drug Product Chemistry, Manufacturing and Controls (CMC) of peptides, proteins, and chemical entities. Advanced bio-pharma CMC technologies, engineering and processes
  • Bioanalysis and biopharmacy (preclinical management and clinical follow-up )
  • Medical technology : devices for administration, design of specific container closure systems
Areas of interest for future collaborations
  • Drug Delivery Systems and Biomedical devices
  • Controlled release formulations
  • Injectable and Loco-regional therapy
  • Drug product and process development , CMC
  • Healthcare and Lifesciences
  • Life Cycle management and reprofiling
  • Formulation of peptides and proteins
  • Advanced physico-Chemistry, self-assembly, nanotechnology
  • Process and Engineering from Lab bench to industrial scale-up
  • Biopharmacy